about
The effects of antiepileptic drugs on cognitive functional magnetic resonance imagingPharmaco fMRI: Determining the functional anatomy of the effects of medicationRecent insights into the impairment of memory in epilepsy: transient epileptic amnesia, accelerated long-term forgetting and remote memory impairmentFocal structural changes and cognitive dysfunction in juvenile myoclonic epilepsy.The promise of new antiepileptic drugs.Behaviour, cognition and epilepsy.Cognitive Effects of Low-dose Topiramate Compared with Oxcarbazepine in Epilepsy PatientsCorrelations between Limbic White Matter and Cognitive Function in Temporal-Lobe Epilepsy, Preliminary Findings.Gender and drug effects on neuroimaging in epilepsy.Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms.Reduced anesthetization during the intracarotid amobarbital (Wada) test in patients taking carbonic anhydrase-inhibiting medications.Infantile spasms and Lennox-Gastaut syndrome.Update: new uses for lithium and anticonvulsants.Pharmacotherapy for treatment-resistant schizophrenia.Clinical experience with open-label topiramate use in infants younger than 2 years of age.Subjective memory evaluation before and after temporal lobe epilepsy surgery.Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor.The cognitive impact of antiepileptic drugs.Hippocampal activation correlates with visual confrontation naming: fMRI findings in controls and patients with temporal lobe epilepsy.Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders.Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects.Remote effects of hippocampal sclerosis on effective connectivity during working memory encoding: a case of connectional diaschisis?Topiramate and its clinical applications in epilepsy.A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity.Neurocognitive costs and benefits of psychotropic medications in older adults.The effect of topiramate on cognitive fMRI.The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memoryRufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.Topiramate and cognitive impairment: evidence and clinical implications.BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.Clobazam as an adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder.Treatment of cluster headache with topiramate: effects and side-effects in five patients.Acute topiramate toxicity.Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.Right hippocampal pathology inhibits the Flynn effect in temporal lobe epilepsy.Efficacy and tolerability of topiramate in children younger than 2 years old.
P2860
Q27005706-E22C274A-2921-4C0D-BC7E-04F76702DCE9Q28079241-2CFD4CF1-A1DD-4074-8CE0-84196B9FF185Q28289234-B0D5D037-A4F7-44C1-92D6-667728FACEF0Q30498019-1E729FD8-4E7A-4B74-B9E3-92C2B42A45C2Q30674774-0D1EA693-96E6-4E30-A709-50A42591DC5EQ31026691-B85EBA13-0AA6-4FF3-B959-37F2B0C953DEQ33790784-4284D522-9E32-4BC5-B817-2D45C18DFB46Q33821332-B62794C3-8651-4EA8-AE79-93A70AF7F773Q33952937-BA609EEB-5D6D-4E85-AEB5-CE74BC3F67D8Q34345252-245B148E-526A-4939-ACFE-516932A621F6Q34389266-69B13154-012B-443A-9EAE-70863772020DQ34599704-1CFAD55A-1092-4DB2-A3A2-66083FDCFE45Q34710521-933ADD48-1684-48C0-A1B6-96E6E0AB0B84Q34879109-9D4C45F5-2D0E-45FE-9FF1-8E5EC379638BQ35132987-323D0F48-847D-41AF-9527-95363CCA8CCEQ35137280-20F77A52-AF89-40D8-9638-045B61DC2971Q35472119-AC5BBA0D-E577-4972-A25F-C5B8430634F8Q35588407-D3C37D90-7EB3-4956-A6A6-4586F9981176Q35590477-450C8EF5-1235-45F1-99EC-A99926264D23Q35618437-3281C034-A8E4-4CA6-BC00-DACF2156D1CFQ35629744-2FE4E028-6655-432A-9F1B-6741B1C4FA90Q35852049-65A8E819-6809-466E-A0C9-D5AC81F3F5D9Q35939580-6595D18D-B39D-4C36-BD88-621C82248E72Q35976184-C30CF5D2-49A5-438F-8127-FB2A969814A0Q36429751-6EDC58A6-5E93-47CB-884D-EA4466AEDA6FQ36928610-C8982ED2-AE63-4F27-B037-852E2E372EA5Q36999739-32C606B4-7145-4ACB-A3FA-F54B4A3F706FQ37001163-8CAD0D62-4780-49CF-8182-914F0E3CE876Q37050594-86020614-B8DD-4B2A-9C02-C61A6398798BQ37244159-459E7AD5-C22A-4B64-9DF3-3E5E94E53C2EQ37983919-8E7D452D-F60C-4EFE-9F6F-0EE738B62944Q38235953-82DD2026-4303-44FC-93A5-1A82CF762847Q38826206-F0B786B9-F348-47F4-B68C-7467981C26A8Q39416423-B9A7C966-A5CF-46E7-ADA5-B0B92F49A00BQ43734626-D6D7C6C0-865E-4897-AF20-D2AB529B9520Q44016420-E67A7CDF-6E14-44E8-802B-41DB2A263A5DQ44713657-F3BE48F1-70E2-4AD8-97CE-2498F16F024BQ45810988-F87A3FF9-ECAE-41D5-BA38-8ED8B105F304Q45900938-5303DAC6-161F-48AC-B7CE-D7B5B87FFD1FQ46753510-F87656CE-137B-47B6-AAE5-F09F7C29112E
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Effects of topiramate on cognitive function.
@ast
Effects of topiramate on cognitive function.
@en
type
label
Effects of topiramate on cognitive function.
@ast
Effects of topiramate on cognitive function.
@en
prefLabel
Effects of topiramate on cognitive function.
@ast
Effects of topiramate on cognitive function.
@en
P2093
P2860
P356
P1476
Effects of topiramate on cognitive function.
@en
P2093
J S Duncan
J W Sander
P J Thompson
S A Baxendale
P2860
P304
P356
10.1136/JNNP.69.5.636
P407
P577
2000-11-01T00:00:00Z